Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study
Clinical trial NCT02148549 · COMPLETED
Trial details
- NCT number
- NCT02148549
- Sponsor
- Wakayama Medical University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-02-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.